Obesity – I8F-MC-GPIJ

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults with Obesity

Register Today!

Trial Information

Start DateOctober 2022
End DateTBD
Trial Duration5 years
Number of Visits28
Lead CRCCaitlyn Van Zon

For additional information
on this trial contact: